Clinical Trials Directory

Trials / Completed

CompletedNCT00765440

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

Role of Peri-operative Immunonutrition in Cancers of the Higher Aero-digestive Tract

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
311 (actual)
Sponsor
Centre Antoine Lacassagne · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: It is not yet known which regimen of enteral nutrition is more effective in preventing infections in patients undergoing surgery for cancer of the upper aerodigestive tract. PURPOSE: This randomized phase III trial is comparing three nutrition regimens in treating patients with cancer of the upper aerodigestive tract.

Detailed description

OBJECTIVES: Primary * Determine the efficacy of immunonutrition (IMPACT®) in patients with de novo cancer of the upper aerodigestive tract. Secondary * Determine the best time to initiate treatment. * Compare the intermediate duration of treatment. * Compare nutritional parameters. OUTLINE: This is a multicenter study. Patients are randomized to 1 of 3 treatment arms. * Arm I: Patients receive standard oral or enteral nutrition (IMPACT® placebo) over 7 days prior to surgery and over 7 days after surgery. * Arm II: Patients receive oral or enteral neoadjuvant IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant standard nutrition (IMPACT® placebo) over 7 days after surgery. * Arm III: Patients receive oral or enteral IMPACT® nutrition over 7 days prior to surgery and enteral adjuvant IMPACT® nutrition over 7 days after surgery. After completion of study therapy, patients are followed at 30 days after surgery and then at 2 and 3 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTtherapeutic nutritional supplementationGiven orally
OTHERplaceboGiven orally

Timeline

Start date
2007-07-01
Primary completion
2009-07-01
Completion
2011-04-01
First posted
2008-10-03
Last updated
2025-09-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00765440. Inclusion in this directory is not an endorsement.